Exploring antagonists of H3R has been under scrutiny as a therapeutic for various CNS disorders, encompassing AD, epilepsy, narcolepsy, ADHD, and learning deficits induced by fetal alcohol exposure [26,27]. Here, HRH3 is linked to narcolepsy.